All In MedTech

Device Trial Radar · NCT06699940

A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents

A Retrospective Registry Study to Evaluate Application of NeuroStar® Advanced Therapy for Depression and Comorbid Anxiety in Adolescents

Last checked: Nov 20, 2026Latest source record: Jan 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

7,690

Actual

Start

May 1, 2023

Primary completion

May 1, 2023

Study completion May 1, 2023

Sponsor

Lead sponsor
NeuroneticsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 21, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 12 years, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess the real-world effectiveness of transcranial magnetic stimulation (TMS) for depression in large adolescent and young adult samples.

Conditions

  • MDD

Interventions

  • Transcranial Magnetic StimulationDevice

    Patients between the age of 12-21 received TMS treatment for MDD disorder.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy OutcomeTime frame: 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Neuronetics

    Malvern, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.